• Bismuth Subsalicylate: Next-Gen GI Disorder Research Strateg

  2026-06-10

  Explore how Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) transforms translational GI disorder research through mechanistic insight, workflow optimization, and strategic product selection. This article bridges recent advances in membrane biology and apoptosis detection with the evolving needs of the scientific community, offering evidence-based guidance for experimental rigor and clinical relevance.

• FLT3-TAZ Signaling Drives Drug Resistance in BP-CML

  2026-06-09

  Shin et al. reveal that FLT3 activation, through the FLT3-JAK-STAT3-TAZ-TEAD-CD36 axis, promotes resistance to BCR::ABL1 TKIs in blast phase chronic myeloid leukemia (BP-CML). Their multi-omics approach demonstrates that targeting FLT3 signaling can overcome drug resistance, suggesting new therapeutic avenues for high-risk CML subsets.

• PBS (Phosphate-Buffered Saline): Technical Use and Protocol

  2026-06-09

  PBS (Phosphate-Buffered Saline, SKU K2818) addresses the need for a sterile, isotonic buffer with controlled pH and osmolarity for routine laboratory workflows such as cell washing and substance dilution. This product is not suitable for diagnostic or medical use and is specifically intended for in vitro scientific research protocols.

• Standardized Whole-Blood Stimulation Reveals Metabolic Contr

  2026-06-08

  This protocol study introduces a robust, standardized method for analyzing immune responses through whole-blood stimulation with metabolic modulation. Its practical approach enables detailed assessment of how metabolic inhibitors shape cytokine production, offering a valuable framework for immunometabolism and immuno-oncology research.

• Amikacin Sulfate: Transforming Targeted Delivery in NTM Rese

  2026-06-08

  This thought-leadership article explores the mechanistic precision, translational strategies, and future horizons of Amikacin Sulfate for non-tuberculous mycobacterial (NTM) infection research. Blending molecular insight with actionable guidance, it contextualizes recent advances in dendritic cell-mediated drug delivery—setting a new standard for translational antibiotic research.

• Triamcinolone: Protocol Parameters and Workflow in Research

  2026-06-07

  Triamcinolone is a synthetic glucocorticoid agonist designed for research involving glucocorticoid signaling pathways, anti-inflammatory mechanisms, and immunosuppression studies. It should not be used in diagnostic or clinical settings. Its application requires precise handling, solubilization, and storage to ensure reproducibility and compound stability.

• Mavorixafor hydrochloride (SKU A3174): Reliable CXCR4 Antago

  2026-06-06

  This article delivers laboratory-driven guidance on deploying Mavorixafor hydrochloride (SKU A3174) as a potent and selective CXCR4 antagonist in cell viability, proliferation, and cytotoxicity assays. It addresses real-world research challenges, synthesizes quantitative evidence, and clarifies vendor selection. Researchers will find actionable insights into workflow optimization and robust protocol design.

• Angiotensin III: Translational Leverage in RAAS and Beyond

  2026-06-05

  This article explores Angiotensin III (Arg-Val-Tyr-Ile-His-Pro-Phe) as a mechanistically rich tool bridging cardiovascular and neuroendocrine research. We combine new evidence from viral pathogenesis with practical guidance for translational scientists, highlighting protocol nuances, competitive benchmarking, and the strategic expansion of RAAS peptide research using APExBIO’s Angiotensin III (human, mouse).

• GS-441524 Prodrug: Advanced Workflows for Antiviral Research

  2026-06-05

  Unlock the full research potential of GS-441524 prodrug with evidence-driven protocols and troubleshooting insights. This article connects LC–MS/MS advances, real lab case studies, and APExBIO quality to boost antiviral assay performance and pharmacokinetic clarity.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Precision in Multi-

  2026-06-04

  Explore the FITC Goat Anti-Mouse IgG (H+L) Antibody as a key fluorescein-conjugated secondary antibody driving sensitive mouse IgG detection in multi-omics and translational research. This article reveals advanced technical insights and uniquely integrates multi-omics assay perspectives.

• Niclosamide (SKU B2283): Reliable STAT3 Inhibition in Cancer

  2026-06-04

  This article explores practical laboratory scenarios where Niclosamide (SKU B2283) addresses key workflow challenges in cell viability, apoptosis, and proliferation assays. By grounding recommendations in quantitative evidence and established protocols, researchers can rely on Niclosamide’s robust STAT3 inhibition for reproducible, data-driven cancer research.

• ARCA EGFP mRNA: Optimizing Fluorescence-Based Transfection A

  2026-06-03

  ARCA EGFP mRNA streamlines fluorescence-based transfection assays by delivering robust, quantifiable signals and exceptional stability in mammalian cell workflows. Its advanced ARCA capping and optimized poly(A) tail set new benchmarks for mRNA reporter performance, enabling confident benchmarking and rapid protocol optimization.

• Isoproterenol sulfate dihydrate: Reliable Beta-Adrenergic Si

  2026-06-03

  This scenario-driven article explores real-world laboratory challenges in cardiovascular and GPCR research, demonstrating how Isoproterenol sulfate dihydrate (SKU C6402) addresses reproducibility, solubility, and data fidelity in cell-based assays. Practical Q&A blocks guide biomedical scientists from experimental design to product selection, with evidence-based comparisons and actionable protocol guidance.

• D-Luciferin: Unraveling Bioluminescence for Advanced Oncolog

  2026-06-02

  Explore how D-Luciferin, a premier firefly luciferase substrate, empowers next-generation bioluminescence imaging in oncology. This in-depth analysis highlights mechanistic insights, practical assay optimization, and new translational opportunities beyond conventional workflows.

• Lactylation-Driven KRT19 Fuels NSCLC by Suppressing Senescen

  2026-06-02

  Zhang et al. demonstrate that lactate-driven histone lactylation at H3K18 promotes KRT19 expression, which in turn suppresses cellular senescence and accelerates non-small cell lung cancer (NSCLC) progression. Their mechanistic findings highlight KRT19 as a mediator of immune evasion and a promising therapeutic target for combination strategies in NSCLC.

449 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page